Cost Of Illness: Heart Failure In Ireland

Abstract

provided by nonprofessionals. The costs of indirect care were reported to be considerably higher than the direct costs. Direct annual costs range from 1,869€ for Poland to 22,230$ for the US. The costs for inpatient care generate the main part of the direct economic burden. In the majority of cases the economic impact is referred to the severity of the CHF expressed by the New York Heart Association functional classification (NYHA) stage. The more severe NYHA stages III and IV are associated with higher costs. ConClusions: Our review highlights the considerable and growing economic burden of CHF on the health care systems of developed countries. The COI studies included in this review show large variations in methodology used and the cost results vary as a consequence. Further research is needed to highlight the economic burden of indirect costs of CHF. High quality data from COI studies with a robust methodology applied can inform policy makers about the major cost drivers of CHF and can be used as the basis of further economic evaluations.

An Era of Digital Healthcare—A Comprehensive Review of Sensor Technologies and Telehealth Advancements in Chronic Heart Failure Management

“…It is also the most common cause of CVD-related hospitalization in patients older than 60 years of age [5]. In Ireland, the total cost of HF was estimated at approximately €660 million in 2012, and expenditure per HF admission was estimated to be more than €10,000 [6]. After a decade, the annual record of HF hospital admissions was approximately 5800 in 2022, and the Sensors 2024, 24, 2546 2 of 29 outpatient department (OPD) waiting times varied between 6 and 9 months on average.…”